Compare Eli Lilly And Co (LLY) vs LYFT Inc (LYFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs LYFT Inc — how do they compare? Eli Lilly And Co trades at $1,147.06 (market cap $1.02T), while LYFT Inc trades at $15.4 (market cap $5.86B). The key difference: Eli Lilly And Co is far larger — about 174.1× LYFT Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| LLY | LYFT | |
|---|---|---|
Market Cap | $1.02T | $5.86B |
Sector | Health | Industrials |
52-Week High | $1.24K | $24.57 |
52-Week Low | $625.65 | $12.65 |
Enterprise Value | $1.06T | $5.39B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
